AAAAAA
Results:
1-10
|
Results: 10
Authors:
Stangel, M
Mix, E
Zettl, UK
Gold, R
Citation: M. Stangel et al., Oxides and apoptosis in inflammatory myopathies, MICROSC RES, 55(4), 2001, pp. 249-258
Authors:
Stangel, M
Compston, A
Citation: M. Stangel et A. Compston, Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors, J NEUROIMM, 112(1-2), 2001, pp. 63-71
Authors:
Nguyen, D
Stangel, M
Citation: D. Nguyen et M. Stangel, Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells, DEV BRAIN R, 128(1), 2001, pp. 77-81
Authors:
Buttner, U
Chofflon, M
Hess, K
Kappos, L
Kesselring, J
Ludin, HP
Schluep, M
Vaney, C
Baumhackl, U
Berger, T
Deisenhammer, F
Freimuller, M
Hartung, HP
Kollegger, H
Kristoferitsch, W
Lassmann, H
Markut, H
Vass, K
Altenkirch, H
Boese, J
Gass, A
Gehlen, W
Goebels, N
Haas, J
Haferkamp, G
Heidenreich, F
Heitmann, R
Hemmer, B
Hohlfeld, R
Janzen, RWC
Jugelt, E
Kolmel, W
Konig, N
Kowitzsch, K
Manegold, U
Melms, A
Mertin, J
Petereit, HF
Pette, M
Pohlau, D
Poser, S
Sailer, M
Schmidt, S
Schock, G
Schulz, M
Seidel, D
Stangel, M
Stark, E
Stoll, G
Weinrich, W
Wietholter, H
Zettl, UK
Zipp, F
Zschenderlein, R
Bayas, A
Chan, A
Flachenecker, P
Gold, R
Grauer, O
Jung, S
Kallmann, B
Leussink, V
Maurer, M
Rieckmann, P
Toyka, KV
Weilbach, FX
Citation: U. Buttner et al., Escalating immunomodulatory therapy of multiple sclerosis - 1. Supplement, NERVENARZT, 72(2), 2001, pp. 150-157
Authors:
Stangel, M
Joly, E
Scolding, NJ
Compston, DAS
Citation: M. Stangel et al., Normal polyclonal immunoglobulins ('IVIg') inhibit microglial phagocytosisin vitro, J NEUROIMM, 106(1-2), 2000, pp. 137-144
Authors:
Stangel, M
Compston, A
Scolding, NJ
Citation: M. Stangel et al., Oligodendroglia are protected from antibody-mediated complement injury by normal immunoglobulins ("IVIg''), J NEUROIMM, 103(2), 2000, pp. 195-201
Authors:
Stangel, M
Boegner, F
Klatt, CH
Hofmeister, C
Seyfert, S
Citation: M. Stangel et al., Placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis, J NE NE PSY, 68(1), 2000, pp. 89-92
Authors:
Stangel, M
Stapf, C
Marx, P
Citation: M. Stangel et al., Presentation and prognosis of bilateral infarcts in the territory of the superior cerebellar artery, CEREB DIS, 9(6), 1999, pp. 328-333
Authors:
Stangel, M
Compston, A
Scolding, NJ
Citation: M. Stangel et al., Polyclonal immunoglobulins for intravenous use do not influence the behaviour of cultured oligodendrocytes, J NEUROIMM, 96(2), 1999, pp. 228-233
Authors:
Stangel, M
Toyka, KV
Gold, R
Citation: M. Stangel et al., Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases, ARCH NEUROL, 56(6), 1999, pp. 661-663
Risultati:
1-10
|